Halozyme Therapeutics shares owned by Envestnet Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Envestnet Asset Management
from 13F filings
Historical chart of Envestnet Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Envestnet Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $18M | 247k | 73.34 |
| 2025-06-30 | $14M | 270k | 52.02 |
| 2025-03-31 | $19M | 304k | 63.81 |
| 2024-12-31 | $15M | 303k | 47.81 |
| 2024-09-30 | $20M | 345k | 57.24 |
| 2024-06-30 | $12M | 230k | 52.36 |
| 2024-03-31 | $8.9M | 219k | 40.68 |
| 2023-09-30 | $8.2M | 215k | 38.20 |
| 2023-06-30 | $5.1M | 142k | 36.07 |
| 2023-03-31 | $5.9M | 292k | 20.26 |
| 2022-12-31 | $8.1M | 142k | 56.90 |
| 2022-09-30 | $5.1M | 128k | 39.54 |
| 2022-06-30 | $3.1M | 70k | 44.00 |
| 2022-03-31 | $2.6M | 65k | 39.87 |
| 2021-12-31 | $2.4M | 61k | 40.21 |
| 2021-09-30 | $2.5M | 61k | 40.68 |
| 2021-06-30 | $2.1M | 47k | 45.41 |
| 2021-03-31 | $1.8M | 43k | 41.69 |
| 2020-12-31 | $1.2M | 28k | 42.71 |
| 2020-09-30 | $745k | 28k | 26.28 |
| 2020-06-30 | $416k | 16k | 26.78 |
| 2020-03-31 | $283k | 16k | 18.02 |
| 2019-12-31 | $266k | 15k | 17.72 |
| 2019-09-30 | $223k | 14k | 15.50 |
| 2019-06-30 | $241k | 14k | 17.17 |
| 2019-03-31 | $222k | 14k | 16.13 |
| 2018-12-31 | $264k | 18k | 14.62 |
| 2016-12-31 | $0 | 13 | 0.00 |
| 2016-03-31 | $16k | 1.6k | 9.74 |
| 2015-12-31 | $25k | 1.4k | 17.68 |
| 2015-09-30 | $14k | 1.0k | 13.78 |
More positions owned by Envestnet Asset Management
View all positions for Envestnet Asset Management